Loading…
Loading…
EQUITY / NASDAQ · XNCM
Shuttle Pharmaceuticals Holdings, Inc.
Following is saved. Automatic company research is not available for this coverage; explore the evidence with Research.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →04/01/2026 – 06/30/2026 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗4.17 USD
Observed: 10/02/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
10/02/2026 · 4.17 USD · Volume 4,362
64 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | 2025 / Quarter 2 | Change |
|---|---|---|---|
| Operating profit | -3,949,535 USD | -3,910,406 USD | — |
| Net income | -3,145,539 USD | -3,706,465 USD | — |
| Cash and cash equivalents | 90,238 USD | — | — |
| Total liabilities | 3,628,859 USD | — | — |
| Total equity | 19,182,179 USD | 3,605,519 USD | +432.02% |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 204/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 03/31/2026ConsolidatedUnits · USD | 2025 / Quarter 212/31/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Quarter 307/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 301/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 204/01/2025 – 06/30/2025ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 90,238 USD | — | — | 334,005 USD | 334,005 USD | 2,094,643 USD | — | — |
| Net incomeIncome statement | -3,145,539 USD | -5,298,010 USD | -2,152,471 USD | — | -11,721,669 USD | -2,347,302 USD | -9,106,774 USD | -3,706,465 USD |
| Operating profitIncome statement | -3,949,535 USD | -6,166,357 USD | — | — | -11,916,824 USD | -2,266,942 USD | -9,128,589 USD | -3,910,406 USD |
| Total assetsBalance sheet | 22,811,038 USD | — | — | 10,475,977 USD | 10,475,977 USD | 3,542,927 USD | — | — |
| Total equityBalance sheet | 19,182,179 USD | — | 3,346,371 USD | 2,254,446 USD | 2,254,446 USD | 1,394,161 USD | — | 3,605,519 USD |
| Total liabilitiesBalance sheet | 3,628,859 USD | — | — | 8,221,531 USD | 8,221,531 USD | 2,148,766 USD | — | — |
| Financing cash flowCash flow statement | — | 8,209,824 USD | — | — | 10,952,228 USD | — | 8,683,132 USD | — |
| Investing cash flowCash flow statement | — | -5,468,642 USD | — | — | -3,056,722 USD | — | — | — |
| Operating cash flowCash flow statement | — | -2,984,949 USD | — | — | -9,481,645 USD | — | -8,508,633 USD | — |
| Report source | Open report ↗ Published: 09/24/2026 | Open report ↗ Published: 09/24/2026 | Open report ↗ Published: 09/24/2026 | Open report ↗ Published: 09/24/2026 | Open report ↗ Published: 03/31/2026 | Open report ↗ Published: 11/13/2025 | Open report ↗ Published: 11/13/2025 | Open report ↗ Published: 09/24/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.